Ryan Becker from Spokane is battling a rare medical condition that has left doctors at the Mayo Clinic and Johns Hopkins ...
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement ...
The data covers its efficacy and safety in treating pyoderma gangrenosum (PG) and hidradenitis suppurativa (HS). Chief Medical Officer Camilla Chong highlighted vilobelimab's potential benefits ...
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement ...